Literature DB >> 11891680

Molecular-pathogenetic classification of genetic disorders of the skeleton.

A Superti-Furga1, L Bonafé, D L Rimoin.   

Abstract

Genetic disorders of the skeleton (skeletal dysplasias and dysostoses) are a large and disparate group of diseases whose unifying features are malformation, disproportionate growth, and deformation of the skeleton or of individual bones or groups of bones. To cope with the large number of different disorders, the "Nosology and Classification of the Osteochondrodysplasias," based on clinical and radiographic features, has been designed and revised periodically. Biochemical and molecular features have been partially implemented in the Nosology, but the rapid accumulation of knowledge on genes and proteins cannot be easily merged into the clinical-radiographic classification. We present here, as a complement to the existing Nosology, a classification of genetic disorders of the skeleton based on the structure and function of the causative genes and proteins. This molecular-pathogenetic classification should be helpful in recognizing metabolic and signaling pathways relevant to skeletal development, in pointing out candidate genes and possible therapeutic targets, and more generally in bringing the clinic closer to the basic science laboratory and in promoting research in this field. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11891680

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  23 in total

Review 1.  Genetic disorders of the skeleton: a developmental approach.

Authors:  Uwe Kornak; Stefan Mundlos
Journal:  Am J Hum Genet       Date:  2003-07-31       Impact factor: 11.025

Review 2.  FGFR3-related dwarfism and cell signaling.

Authors:  Daisuke Harada; Yoshitaka Yamanaka; Koso Ueda; Hiroyuki Tanaka; Yoshiki Seino
Journal:  J Bone Miner Metab       Date:  2008-12-09       Impact factor: 2.626

3.  A role for a lithium-inhibited Golgi nucleotidase in skeletal development and sulfation.

Authors:  Joshua P Frederick; A Tsahai Tafari; Sheue-Mei Wu; Louis C Megosh; Shean-Tai Chiou; Ryan P Irving; John D York
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-11       Impact factor: 11.205

4.  Severely incapacitating mutations in patients with extreme short stature identify RNA-processing endoribonuclease RMRP as an essential cell growth regulator.

Authors:  Christian T Thiel; Denise Horn; Bernhard Zabel; Arif B Ekici; Kelly Salinas; Erich Gebhart; Franz Rüschendorf; Heinrich Sticht; Jürgen Spranger; Dietmar Müller; Christiane Zweier; Mark E Schmitt; André Reis; Anita Rauch
Journal:  Am J Hum Genet       Date:  2005-09-29       Impact factor: 11.025

5.  Recurrent dominant mutations affecting two adjacent residues in the motor domain of the monomeric kinesin KIF22 result in skeletal dysplasia and joint laxity.

Authors:  Eric D Boyden; A Belinda Campos-Xavier; Sebastian Kalamajski; Trevor L Cameron; Philippe Suarez; Goranka Tanackovic; Goranka Tanackovich; Generoso Andria; Diana Ballhausen; Michael D Briggs; Claire Hartley; Daniel H Cohn; H Rosemarie Davidson; Christine Hall; Shiro Ikegawa; Pierre-Simon Jouk; Rainer König; André Megarbané; Gen Nishimura; Ralph S Lachman; Geert Mortier; David L Rimoin; R Curtis Rogers; Massimiliano Rossi; Hirotake Sawada; Richard Scott; Sheila Unger; Eugenia Ribeiro Valadares; John F Bateman; Matthew L Warman; Andrea Superti-Furga; Luisa Bonafé
Journal:  Am J Hum Genet       Date:  2011-12-09       Impact factor: 11.025

6.  Dyggve-Melchior-Clausen syndrome: chondrodysplasia resulting from defects in intracellular vesicle traffic.

Authors:  Anna B Osipovich; Jennifer L Jennings; Qing Lin; Andrew J Link; H Earl Ruley
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-13       Impact factor: 11.205

Review 7.  Current themes in molecular pediatrics: molecular medicine and its applications.

Authors:  Andrea Superti-Furga; Livia Garavelli
Journal:  Ital J Pediatr       Date:  2010-02-19       Impact factor: 2.638

8.  Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias.

Authors:  Akihiro Yasoda; Hidetomo Kitamura; Toshihito Fujii; Eri Kondo; Naoaki Murao; Masako Miura; Naotetsu Kanamoto; Yasato Komatsu; Hiroshi Arai; Kazuwa Nakao
Journal:  Endocrinology       Date:  2009-03-12       Impact factor: 4.736

9.  Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia.

Authors:  Matthew J Rock; Jean Prenen; Vincent A Funari; Tara L Funari; Barry Merriman; Stanley F Nelson; Ralph S Lachman; William R Wilcox; Soraya Reyno; Roberto Quadrelli; Alicia Vaglio; Grzegorz Owsianik; Annelies Janssens; Thomas Voets; Shiro Ikegawa; Toshiro Nagai; David L Rimoin; Bernd Nilius; Daniel H Cohn
Journal:  Nat Genet       Date:  2008-06-29       Impact factor: 38.330

10.  Evaluation of prenatal-onset osteochondrodysplasias by ultrasonography: a retrospective and prospective analysis.

Authors:  Deborah Krakow; Yasemin Alanay; Lauren P Rimoin; Victoria Lin; William R Wilcox; Ralph S Lachman; David L Rimoin
Journal:  Am J Med Genet A       Date:  2008-08-01       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.